Andrew Fine

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Chemomab Therapeutics Ltd. publishes a filing, an earnings call transcript or a press release.

Get CMMB alerts

About Andrew Fine

Andrew Fine is recorded as CFO at Chemomab Therapeutics Ltd. (CMMB) since October 20, 2020. Chemomab Therapeutics Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Chemomab Therapeutics Ltd. includes Adi Mor (CEO and Board Member), Dale Pfost (CEO and Board Member), Dr. Adi Mor (CEO) and 7 others.

Affiliation history

Chemomab Therapeutics Ltd. (CMMB)
CFO

SEC 8-K

Current
2020-10-20–present

Company network

Chemomab Therapeutics Ltd.

CMMB

Current role

Biotechnology · Healthcare

CFO

2020-10-20–present

Leadership on record at Chemomab Therapeutics Ltd.

Adi Mor CEO, Board Member
Dale Pfost CEO, Board Member
Dr. Adi Mor CEO
Dr. Dale Pfost CEO
Neil Cohen CEO, Board Member
Dr. Nissim Darvish Chairman
Stephen Squinto Chairman, Board Member
Donald Marvin CFO, COO
Ms. Sigal Fattal CFO
Sigal Fattal CFO

Recent activity

No call appearances or filed executive changes recorded yet.